SE440651B - Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningar - Google Patents
Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningarInfo
- Publication number
- SE440651B SE440651B SE7909367A SE7909367A SE440651B SE 440651 B SE440651 B SE 440651B SE 7909367 A SE7909367 A SE 7909367A SE 7909367 A SE7909367 A SE 7909367A SE 440651 B SE440651 B SE 440651B
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- piperidyl
- compounds
- compound
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 18
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 8
- HNQZRUDJRPSFAU-UHFFFAOYSA-N 2-piperidin-1-yl-1h-indole Chemical class C1CCCCN1C1=CC2=CC=CC=C2N1 HNQZRUDJRPSFAU-UHFFFAOYSA-N 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- -1 piperidone chlorohydrate Chemical compound 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 239000000935 antidepressant agent Substances 0.000 claims description 2
- 229940005513 antidepressants Drugs 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 2
- 208000009132 Catalepsy Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010047853 Waxy flexibility Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- WIKYUJGCLQQFNW-UHFFFAOYSA-N prochlorperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 WIKYUJGCLQQFNW-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- PYHRZPFZZDCOPH-QXGOIDDHSA-N (S)-amphetamine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C[C@H](N)CC1=CC=CC=C1.C[C@H](N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-QXGOIDDHSA-N 0.000 description 1
- MYTGFBZJLDLWQG-UHFFFAOYSA-N 5-chloro-1h-indole Chemical compound ClC1=CC=C2NC=CC2=C1 MYTGFBZJLDLWQG-UHFFFAOYSA-N 0.000 description 1
- DWAQDRSOVMLGRQ-UHFFFAOYSA-N 5-methoxyindole Chemical compound COC1=CC=C2NC=CC2=C1 DWAQDRSOVMLGRQ-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- QJRWYBIKLXNYLF-UHFFFAOYSA-N 6-methoxy-1h-indole Chemical compound COC1=CC=C2C=CNC2=C1 QJRWYBIKLXNYLF-UHFFFAOYSA-N 0.000 description 1
- IRCNPZHVILGXDR-UHFFFAOYSA-N 6-methoxy-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole Chemical compound COC1=C(C=C2C=CNC2=C1)C=1CCNCC=1 IRCNPZHVILGXDR-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 206010001541 Akinesia Diseases 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 208000022821 personality disease Diseases 0.000 description 1
- GJQNVZVOTKFLIU-UHFFFAOYSA-N piperidin-1-ium-4-one;chloride Chemical compound Cl.O=C1CCNCC1 GJQNVZVOTKFLIU-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7836167A FR2444678A2 (fr) | 1978-12-22 | 1978-12-22 | Nouveau procede de preparation de derives du piperidyl-indole et de leurs sels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7909367L SE7909367L (sv) | 1980-06-23 |
| SE440651B true SE440651B (sv) | 1985-08-12 |
Family
ID=9216467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7909367A SE440651B (sv) | 1978-12-22 | 1979-11-13 | Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningar |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4232031A (de) |
| JP (1) | JPS5587786A (de) |
| AT (1) | AT375361B (de) |
| AU (1) | AU529439B2 (de) |
| BE (1) | BE880818A (de) |
| CA (1) | CA1128946A (de) |
| CH (1) | CH642963A5 (de) |
| DE (1) | DE2951912A1 (de) |
| ES (1) | ES487175A1 (de) |
| FR (1) | FR2444678A2 (de) |
| GB (1) | GB2039277B (de) |
| HU (1) | HU181947B (de) |
| IE (1) | IE49343B1 (de) |
| IT (1) | IT1164031B (de) |
| NL (1) | NL7909136A (de) |
| SE (1) | SE440651B (de) |
| ZA (1) | ZA796386B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2420536A1 (fr) * | 1978-03-22 | 1979-10-19 | Roussel Uclaf | Nouveaux derives de 1,3-dihydro 3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl)2-hydroxyethyl/piperidin-4-yl/2h-indol-2-one, procede pour leur preparation et application comme medicaments |
| SE8004129L (sv) * | 1979-07-13 | 1981-01-14 | Roussel Uclaf | Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar |
| FR2460947A1 (fr) * | 1979-07-13 | 1981-01-30 | Roussel Uclaf | Nouveau derives n-substitues du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| MX19185A (es) * | 1989-01-20 | 1993-12-01 | Pfizer | Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas. |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| JPWO2004069828A1 (ja) * | 2003-02-04 | 2006-05-25 | 三菱ウェルファーマ株式会社 | ピペリジン化合物およびその医薬用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2872453A (en) * | 1959-02-03 | Indole derivatives | ||
| FR2193584B1 (de) * | 1972-07-28 | 1975-08-08 | Roussel Uclaf | |
| DE2322470A1 (de) * | 1973-05-04 | 1974-11-21 | Boehringer Sohn Ingelheim | Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung |
| FR2258843B1 (de) * | 1974-01-30 | 1977-09-09 | Roussel Uclaf | |
| IL48508A (en) * | 1974-12-09 | 1979-10-31 | Roussel Uclaf | Pharmaceutical compositions comprising piperidylindole derivatives |
| JPS5283766A (en) * | 1976-01-01 | 1977-07-12 | Roussel Uclaf | Piperidyl indole derivative and its salts and medicine comprising same |
| FR2349331A1 (fr) * | 1976-04-30 | 1977-11-25 | Roussel Uclaf | Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments |
| FR2362628A1 (fr) * | 1976-08-26 | 1978-03-24 | Roussel Uclaf | Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments |
-
1978
- 1978-12-22 FR FR7836167A patent/FR2444678A2/fr active Granted
-
1979
- 1979-11-13 SE SE7909367A patent/SE440651B/sv not_active IP Right Cessation
- 1979-11-26 ZA ZA00796386A patent/ZA796386B/xx unknown
- 1979-11-27 HU HU79RO1048A patent/HU181947B/hu not_active IP Right Cessation
- 1979-12-06 US US06/100,909 patent/US4232031A/en not_active Expired - Lifetime
- 1979-12-18 JP JP16364679A patent/JPS5587786A/ja active Granted
- 1979-12-19 NL NL7909136A patent/NL7909136A/nl not_active Application Discontinuation
- 1979-12-20 CA CA342,441A patent/CA1128946A/fr not_active Expired
- 1979-12-21 ES ES487175A patent/ES487175A1/es not_active Expired
- 1979-12-21 BE BE0/198712A patent/BE880818A/fr not_active IP Right Cessation
- 1979-12-21 DE DE19792951912 patent/DE2951912A1/de active Granted
- 1979-12-21 AT AT0809679A patent/AT375361B/de not_active IP Right Cessation
- 1979-12-21 IT IT51166/79A patent/IT1164031B/it active
- 1979-12-21 AU AU54152/79A patent/AU529439B2/en not_active Ceased
- 1979-12-21 IE IE2508/79A patent/IE49343B1/en unknown
- 1979-12-21 CH CH1142679A patent/CH642963A5/fr not_active IP Right Cessation
- 1979-12-24 GB GB7944358A patent/GB2039277B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AT375361B (de) | 1984-07-25 |
| ZA796386B (en) | 1980-10-29 |
| BE880818A (fr) | 1980-06-23 |
| JPS5587786A (en) | 1980-07-02 |
| US4232031A (en) | 1980-11-04 |
| FR2444678A2 (fr) | 1980-07-18 |
| AU5415279A (en) | 1980-06-26 |
| CA1128946A (fr) | 1982-08-03 |
| DE2951912C2 (de) | 1989-05-11 |
| CH642963A5 (fr) | 1984-05-15 |
| IT7951166A0 (it) | 1979-12-21 |
| IT1164031B (it) | 1987-04-08 |
| GB2039277B (en) | 1983-03-02 |
| NL7909136A (nl) | 1980-06-24 |
| ES487175A1 (es) | 1980-09-16 |
| SE7909367L (sv) | 1980-06-23 |
| DE2951912A1 (de) | 1980-07-10 |
| AU529439B2 (en) | 1983-06-09 |
| JPS6345387B2 (de) | 1988-09-09 |
| HU181947B (en) | 1983-11-28 |
| IE49343B1 (en) | 1985-09-18 |
| ATA809679A (de) | 1983-12-15 |
| GB2039277A (en) | 1980-08-06 |
| FR2444678B2 (de) | 1982-09-17 |
| IE792508L (en) | 1980-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3688827T2 (de) | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. | |
| JPS6340792B2 (de) | ||
| DE2738646C2 (de) | Piperidyl-indol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| CZ398191A3 (en) | Novel 4-amino alkyl-2(3h)-indolones and pharmaceutical compositions containing them | |
| BG61120B2 (bg) | Производни на 1,2,5,6-тетрахидропиридин-3-карбоксалдехид оксим,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави | |
| EP0280269A1 (de) | 3-Amino-dihydro-[1]-benzopyrane und Benzothiopyrane | |
| SE440651B (sv) | Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningar | |
| CA1340986C (fr) | Derives de la 1,2,5,6-tetrahydropyridine, leur procede de preparation, leur application comme medicaments et les compositions les renfermant | |
| JP2660430B2 (ja) | 新規の１，２，５，６−テトラヒドロピリジン−３−カルボキサアルデヒドのオキシム誘導体、それらの製造方法、それらの薬剤としての使用及びそれらを含有する組成物 | |
| HU184988B (en) | Process for producing pyrrolidine derivatives | |
| JPH02262580A (ja) | チアゾリル又はオキサゾリル基で置換された１，２，５，６―テトラヒドロピリジンの新規の誘導体、それらの製造方法及び中間体、それらの薬剤としての使用並びにそれらを含有する組成物 | |
| CA1145752A (fr) | Procede de preparation de nouveaux derives du n'tetrahydropyridinyl-indoles et de leurs sels | |
| US4927837A (en) | Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments | |
| DE3320102C2 (de) | ||
| WO1989005799A1 (en) | Novel tetrahydropyridine derivatives, pharmaceutical compositions containing them and process for preparing same | |
| EP0308283A1 (de) | 1,2,5,6-Tetrahydropyridin-3-carboxaldehydoxim-Derivate, Verfahren zu deren Herstellung, deren Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen | |
| DE69715196T2 (de) | Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)-nipecotinsäure | |
| HU210154B (en) | Process for producing new famotidin-salts and pharmaceutical compositions of gastro-acid-secretion-inhibiting and gastro-citoprotective activity, containing them | |
| HU184791B (en) | Process for preparing derivatives of tetrahydro-pyrid-4-yl-indole | |
| NL8703003A (nl) | Nieuwe azaspirodecaanverbindingen, hun zouten, werkwijze voor hun bereiding, hun toepassing als geneesmiddelen en preparaten, die hen bevatten. | |
| DE3874030T2 (de) | 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel. | |
| DE69705429T2 (de) | 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit | |
| US5183896A (en) | Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime | |
| EP0012347A1 (de) | 7,8,9,10-Tetrahydrothieno(3,2-e)pyrido(4,3-b)indole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| HU184233B (en) | Process for preparing 4-amino-substituted-2-piperidino-quinazoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7909367-0 Effective date: 19920604 Format of ref document f/p: F |